Abstract
Near infrared spectroscopy offers a qualitative, noninvasive indication of mixed venous oxygen saturation in PAH http://ow.ly/TSSx30231YO
To the Editor:
Pulmonary arterial hypertension (PAH) is characterised by increased pulmonary vascular resistance and results in increased morbidity and mortality due to right heart failure and a progressive decline in cardiac output [1, 2]. The latter disturbs oxygen delivery to the periphery and may lead to pathological changes in tissue oxygenation. The balance between global oxygen supply and demand is reflected in mixed venous oxygen saturation (SvO2), an index that is generally reduced in patients with PAH [3]. SvO2 at baseline is one of the strongest predictors of survival in PAH [4–6]; this is also true for changes in SvO2 during follow-up [5]. Cut-off values of 60% [7] and 65% [5] have been used to distinguish between prognostic groups suggesting that these may be suitable treatment goals. SvO2 is measured invasively in the pulmonary artery, where venous blood mixes after circulating through the superior and inferior vena cava, coronary sinuses and the right-heart chambers.
Spatially resolved near infrared spectroscopy (NIRS) offers a noninvasive, rapidly responsive method for measuring skeletal muscle oxygenation by examining absorption differences in the near-infrared spectrum of light between oxy- and deoxy- haemoglobin and myoglobin molecules in the microvasculature. The tissue oxygenation index (StO2) is commonly adopted as an index of the dynamic balance between local tissue oxygen supply (availability) and utilisation (extraction) in both health and disease [8, 9]. Because the contribution of the myoglobin to the NIRS signal is not critical, StO2 is largely considered as the ratio of oxygenated to total tissue haemoglobin concentration expressed as (oxyhaemoglobin/(oxyhaemoglobin+deoxyhaemoglobin))×100%. To evaluate NIRS in PAH, we correlated measurements of StO2 with SvO2 and venous oxygen saturation in the inferior vena cava (SivcO2) during right heart catheterisation.
To measure StO2, one transcutaneous sensor (S-Type Probe, NIRO-200NX spatially resolved spectrophotometer; Hamamatsu Photonics KK, Hamamatsu, Japan) was placed over each vastus lateralis muscle, 10–12 cm above the lateral epicondyle. StO2 values shown are the average values obtained from both legs at the time of concurrent SvO2 and SivcO2 measurements. SvO2 was measured from the distal port of the Swan–Ganz catheter. SivcO2 was measured with a pigtail catheter advanced through the right internal jugular vein sheath to the level of S1 vertebra.
Concurrent, single-point measurements of SvO2 and StO2 were repeated at supine exercise in consecutive patients who consented to this task. One patient performed straight leg raising and nine patients exercised on an electronically braked lower limb cycle ergometer secured to the catheterisation table. Subjects cycled at 60 revolutions·min−1 for 6 min at a constant workload set at 50% of peak work rate achieved during an upright cycle cardiopulmonary exercise test the previous day. SvO2 and StO2 were measured during the sixth minute of exercise. Supplementary oxygen was provided as required to minimise arterial hypoxaemia.
25 subjects with PAH (13 idiopathic PAH; one familial PAH; seven connective tissue disease-associated PAH; one congenital heart disease-associated PAH; three portopulmonary arterial hypertension) were studied at rest, 10 of whom also exercised. Resting mean pulmonary artery pressure, cardiac output and pulmonary vascular resistance were 43±11 mmHg, 4.6±1.7 L·min−1 and 9.5±5.9 Wood units, respectively.
Combining all the resting and exercise data points (n=35), StO2 showed a strong correlation with SvO2 (r=0.703, p<0.001). This level of correlation persisted when looking separately at rest (StO2: 73.1±9.8%, SvO2: 62.5±12.9%; r=0.701, p<0.001) and exercise data (StO2: 69.2±9.2%, SvO2: 42.3±16.6%; r=0.863, p=0.001) (figure 1) but also, the change in StO2 and SvO2 from rest to exercise (r=0.669, p=0.034). A significant reduction was observed in StO2 during exercise (from 77.6±6.9% to 69.2±9.2%; p<0.001). Resting values of StO2 exhibited similar level of correlation with SivcO2 (64.2±14.3%; r=0.655, p=0.001). A strong correlation (r=0.795, p<0.001) was observed between SivcO2 and SvO2, whereas the resting correlations of StO2 with SvO2 and SivcO2 were not statistically different (Z=0.3, p=0.76).
Patient characteristics and correlations between tissue oxygenation index (StO2) and mixed venous oxygen saturation (SvO2) at a) rest and b) exercise.
Resting StO2 correlated with age (r=−0.416, p=0.038) and indices of disease severity including the 6-min walk distance (r=0.528, p=0.008), N-terminal pro-brain natriuretic peptide (r=−0.395, p=0.05) and diffusing lung capacity for carbon monoxide % predicted (r=0.398, p=0.049).
To our knowledge, this is the first study to report on the association between StO2 and SvO2. Significant correlation between vastus lateralis StO2 and femoral venous oxygen saturation has been reported in healthy trained subjects [10]; although, earlier studies failed to confirm such correlation [11, 12]. However, comparisons should be made with caution as responses of StO2 depend highly on the mode, intensity and duration of exercise and neither of those studies was matched in design to our resting and steady-state exercise protocol. Instead, they reported on measurements either during incremental exercise [10] or over time during constant-load exercise [11, 12].
Nonetheless, the correlation between StO2 and SvO2 or SivcO2 is not absolute and results of relating StO2 to venous blood oxygenation should not be interpreted in a quantitative sense. This may be because the specific tissue volume investigated by NIRS is not fully representative of the oxygen status of the body segment (lower limb) or global tissue oxygenation as measured by SivcO2 and SvO2, respectively [8]. It is not surprising that the highest correlations between StO2 and venous oxygen saturation were shown when the sampled venous effluent was specific for the interrogated tissue volume such as that obtained from a deep forearm vein that drained the exercising human muscle (r=0.92) [9] or from a vein that drained only the electrically simulated canine muscle (r=0.97) [13]. Accordingly, StO2 would be expected to exhibit a higher correlation with SivcO2 than SvO2; however, we observed similar correlations with SivcO2 and SvO2. This seeming paradox may be due to venous return from the lower limbs being the major determinant of SvO2 in the supine leg exercise.
The design of the present study does not allow for reliable conclusions on the tissue oxygen status per se; the presented findings should be interpreted within the context of oxygen supplementation to maintain resting normoxaemia and the absence of a matched control group. However, our findings provide support for the use of NIRS in the investigation of the pathophysiological abnormalities in PAH. Also, taken together, findings cannot exclude a role of the periphery in the pathophysiology of PAH. Indeed, skeletal muscle tissue microenvironment, an important factor of the local oxygen status, is disturbed in PAH [14]. Perhaps, combination of NIRS with other techniques such as vascular occlusion, sidestream dark field imaging and histological examination could enable further exploration.
Limited experience from application of NIRS in PAH showed significantly lower resting thenar muscle oxygen saturation in PAH patients compared to matched healthy subjects and patients with chronic heart failure [15]. Also, study of the kinetics of the vastus lateralis fractional oxygen extraction (% Δ deoxyhaemoglobin/myoglobin) relative to oxygen uptake at the beginning of heavy-intensity exercise, suggested that patients with PAH have greater microvascular oxygen delivery-to-utilisation inequalities compared to healthy controls, which contributes to a slow adaptation rate of aerobic metabolism [16].
In summary, skeletal muscle StO2 in PAH subjects correlated significantly with SvO2 under both resting and exercise conditions. Also, StO2 correlated significantly, albeit weakly, with indices of disease severity. These novel findings suggest that StO2 may serve as a clinical and research tool for the qualitative, noninvasive assessment of the dynamic balance between oxygen supply and utilisation in PAH. Further studies are warranted to explore the value of NIRS in the assessment and prognosis of PAH.
Footnotes
Support statement: Marios Panagiotou is the recipient of an ERS PAH Long-Term Research fellowship number LTRF 2014-3106 supported by an unrestricted grant by GSK. Funding information for this article has been deposited with the Open Funder Registry.
Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com
- Received March 24, 2016.
- Accepted June 13, 2016.
- Copyright ©ERS 2016